Hi Survivor - I haven't been following closely, or posting, but basically the volume speaks for itself. No news other than failure to follow through on promised filings and uplistings. Errors in picking consultants seem to be the only thing that one can assume will happen with regularity. There are health issues that have hurt the CEO unfortunately and everyone wishes them well, but that doesn't mitigate the failures to perform that have just about destroyed credibility, frankly speaking.
The only positive sign, taking a contrarian view, are dedicated RB "cyber sleupps" who spam generic stuff like, "it's a scam, and imho it's going to .001 or .0001."
Not that I give advice, but if I were to, I'd say, "stay away" at least until you see a filing and trustworthy numbers. I don't have a problem with the lack of uplisting, but I do have a problem with promised uplisting and dates targeted, coupled with failure to perform.
The stock can't really be traded, given the lack of volume, and objectively, as an investment, it has lost credibility. That can be regained, but not with mere words.
best wishes for the holidays and new year. |
